AgingClinicalandExperimentalResearch
Review.OtolaryngolHeadNeckSurg148:374–382.https://doi.77.ChamberlainS,BirringSS,GarrodR(2014)Nonpharmaco-
org/10.1177/0194599812471817logicalinterventionsforrefractorychroniccoughpatients:
63.RyanMA,CohenSM(2016)Long-termfollow-upofamitrip-systematicreview.Lung192:75–85.https://doi.org/10.1007/
tylinetreatmentforidiopathiccough.Laryngoscope126:2758–s00408-013-9508-y
2763.https://doi.org/10.1002/lary.2597878.FinleyCR,ChanDS,GarrisonSet?al(2018)Whatarethemost
64.JeyakumarA,BrickmanTM,HabenM(2006)Effectivenesscommonconditionsinprimarycare?Systematicreview.CanFam
ofamitriptylineversuscoughsuppressantsinthetreatmentofPhysician64:832–840
chroniccoughresultingfrompostviralvagalneuropathy.Laryn-79.SmithJA,WoodcockA(2016)ChronicCough.NEnglJMed
goscope116:2108–2112.https://doi.org/10.1097/01.mlg.00002375:1544–1551.https://doi.org/10.1056/NEJMcp1414215
44377.60334.e380.MikamiM,TomitaK,YamasakiA(2021)AHistoryofRecurrent
65.MoriceAH,MenonMS,MulrennanSAet?al(2007)Opiatether-EpisodesofProlongedCoughasaPredictiveValueforDetermin-
apyinchroniccough.AmJRespirCritCareMed175:312–315.ingCoughVariantAsthmainaPrimaryCareSetting.Yonago
https://doi.org/10.1164/rccm.200607-892OCActaMed64:353–359.https://doi.org/10.33160/yam.2021.11.005
66.VaeziMF,KatzkaD,ZerbibF(2018)ExtraesophagealSymptoms81.TurnerRD,BothamleyGH(2016)Chroniccoughandanormal
andDiseasesAttributedtoGERD:WhereisthePendulumSwing-chestX-ray-asimplesystematicapproachtoexcludecommon
ingNow?ClinGastroenterolHepatol16:1018–1029.https://doi.causesbeforereferraltosecondarycare:aretrospectivecohort
org/10.1016/j.cgh.2018.02.001study.NPJPrimCareRespirMed26:15081.https://doi.org/10.
67.ShaheenNJ,CrockettSD,BrightSDet?al(2011)Randomised1038/npjpcrm.2015.81
clinicaltrial:high-doseacidsuppressionforchroniccough-a82.SongW-J,WonH-K,AnJet?al(2019)Chroniccoughinthe
double-blind,placebo-controlledstudy.AlimentPharmacolTherelderly.PulmPharmacolTher56:63–68.https://doi.org/10.1016/j.
33:225–234.https://doi.org/10.1111/j.1365-2036.2010.04511.xpupt.2019.03.010
68.BaldiF,CappielloR,CavoliCet?al(2006)Protonpumpinhibitor83.SohnK-H,SongW-J,KimS-Het?al(2019)Chroniccough,not
treatmentofpatientswithgastroesophagealreflux-relatedchronicasthma,isassociatedwithdepressionintheelderly:acommunity-
cough:acomparisonbetweentwodifferentdailydosesoflanso-basedpopulationanalysisinSouthKorea.KoreanJInternMed
prazole.WorldJGastroenterol12:82–88.https://doi.org/10.3748/34:1363–1371.https://doi.org/10.3904/kjim.2018.187
wjg.v12.i1.8284.WonH-K,YoonS-J,SongW-J(2018)Thedouble-sidednessof
69.CharbelS,KhandwalaF,VaeziMF(2005)Theroleofesophagealcoughintheelderly.RespirPhysiolNeurobiol257:65–69.https://
pHmonitoringinsymptomaticpatientsonPPItherapy.AmJdoi.org/10.1016/j.resp.2018.01.009
Gastroenterol100:283–289.https://doi.org/10.1111/j.1572-0241.85.SobczakPA,SobczakJM,MajewskiSet?al(2020)Theroleof
2005.41210.xbronchoscopyindiagnosisofchroniccoughinadults:aretrospec-
70.GlicksmanJT,MickPT,FungKet?al(2014)Prokineticagentstivesingle-centerstudy.AdvRespirMed88:406–411.https://doi.
andlaryngopharyngealrefluxdisease:Prokineticagentsandlar-org/10.5603/ARM.a2020.0140
yngopharyngealrefluxdisease:asystematicreview.Laryngoscope86.HechingM,RosengartenD,ShitenbergDet?al(2020)Bronchos-
124:2375–2379.https://doi.org/10.1002/lary.24738copyforChronicUnexplainedCough:UseofBiopsiesandCul-
71.MarchantJ,MastersIB,ChampionAet?al(2012)RandomisedturesIncreaseDiagnosticYield.JBronchologyIntervPulmonol
controlledtrialofamoxycillinclavulanateinchildrenwithchronic27:30–35.https://doi.org/10.1097/LBR.0000000000000629
wetcough.Thorax67:689–693.https://doi.org/10.1136/thora87.AltmanKW,LaneAP,IrwinRS(2019)OtolaryngologyAspects
xjnl-2011-201506ofChronicCough.JAllergyClinImmunolPract7:1750–1755.
72.BelvisiMG,BirrellMA,WortleyMAet?al(2017)XEN-D0501,https://doi.org/10.1016/j.jaip.2019.04.009
aNovelTransientReceptorPotentialVanilloid1Antagonist,88.RouadiPW,IdrissSA,BousquetJet?al(2021)WAO-ARIAcon-
DoesNotReduceCoughinPatientswithRefractoryCough.Amsensusonchroniccough-PartII:Phenotypesandmechanisms
JRespirCritCareMed196:1255–1263.https://doi.org/10.1164/ofabnormalcoughpresentation—UpdatesinCOVID-19.World
rccm.201704-0769OCAllergyOrganJ14:100618.https://doi.org/10.1016/j.waojou.
73.KhalidS,MurdochR,NewlandsAet?al(2014)Transientreceptor2021.100618
potentialvanilloid1(TRPV1)antagonisminpatientswithrefrac-89.?olakY,AfzalS,LangePet?al(2019)RoleandImpactofChronic
torychroniccough:adouble-blindrandomizedcontrolledtrial.JCoughinIndividualswithAsthmaFromtheGeneralPopulation.
AllergyClinImmunol134:56–62.https://doi.org/10.1016/j.jaci.JAllergyClinImmunolPract7:1783-1792.e8.https://doi.org/10.
2014.01.0381016/j.jaip.2019.02.021
74.BonviniSJ,BelvisiMG(2017)Coughandairwaydisease:The90.HamblinM,ProschH,Va?ákováM(2022)Diagnosis,courseand
roleofionchannels.PulmPharmacolTher47:21–28.https://doi.managementofhypersensitivitypneumonitis.EurRespirRev.
org/10.1016/j.pupt.2017.06.009https://doi.org/10.1183/16000617.0169-2021
75.McGarveyLP,BirringSS,MoriceAHet?al(2022)Efficacyand91.Fernandez-RandoM,HerreraMD,Almeida-GonzálezCVet?al
safetyofgefapixant,aP2X3receptorantagonist,inrefractory(2021)DaysNeededfortheDisappearanceofaCoughDuetothe
chroniccoughandunexplainedchroniccough(COUGH-1andUseofanAngiotensin-ConvertingEnzymeInhibitorandIdenti-
COUGH-2):resultsfromtwodouble-blind,randomised,parallel-ficationofPredisposingFactorsAssociatedWithItsAppearance
group,placebo-controlled,phase3trials.Lancet399:909–923.inaClinicalCohortofHypertensivePatients.JClinPharmacol
https://doi.org/10.1016/S0140-6736(21)02348-561:591–597.https://doi.org/10.1002/jcph.1786
76.VertiganAE,TheodorosDG,GibsonPGet?al(2006)Efficacyof
speechpathologymanagementforchroniccough:arandomisedPublisher''sNoteSpringerNatureremainsneutralwithregardto
placebocontrolledtrialoftreatmentefficacy.Thorax61:1065–jurisdictionalclaimsinpublishedmapsandinstitutionalaffiliations.
1069.https://doi.org/10.1136/thx.2006.064337
13
|
|
